Amoxicillin
| Amoxicillin | |
|---|---|
| Salts [] | |
|---|---|
| Sodium amoxicillin | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 365.40 g/mol [1] |
| Appearance | Crystals from water [1] |
| Odor | Penicillin-type odor [1] |
| Taste | Bitter tasting [1] |
| Melting point | 194 °C [1] |
| Boiling point | 743.2 [1] |
| Solubility | Soluble in water [1] |
| Predicted LogP | -2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H19N3O5S |
| IUPAC name | (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| SMILES | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C |
| InChI | InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1 |
| InChIKey | LSQZJLSUYDQPKJ-NJBDSQKTSA-N |
| CAS number | 26787-78-0 |
| UNII | 9EM05410Q9 |
| PubChem CID | 33613 |
| Pharmacokinetics[] | |
|---|---|
| Onset | ≤1.3–1.5 hours (time to peak concentrations) |
| Elimination half-life | 61.3 minutes (~1 hour) |
| Metabolism | Hydroxylation, oxidative deamination, aliphatic chain oxidation, decarboxylation, glucuronidation |
| Excretion | Urine: 70–78% (after 6 hours) |
| Routes of administration | By mouth, intravenous (bolus), intramuscular |
Amoxicillin (also known as Amoxycillin, Amoxicillin anhydrous, Amoxicilline, Amopenixin, D-Amoxicillin, p-Hydroxyampicillin, Amoxicilina, Amoxil, Amolin or Moxal) is a antibiotic substance of the phenethylamine and amino acid class.
Chemistry
Salts []
Stereochemistry []
Amoxicillin is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Amoxicillin matches Lipinski's rule of five.Pharmacology
ATC Classification
- antiinfectives for systemic use (J)
- antibacterials for systemic use (J01)
- beta-lactam antibacterials, penicillins (J01C)
- penicillins with extended spectrum (J01CA)
- (J01CA04)
- amoxicillin (J01CA04)
MeSH Classification
- anti-bacterial agents (M0448397)
Mechanism of action []
Amoxicillin competitively inhibits penicillin-binding protein 1 and other high molecular weight penicillin binding proteins. Penicillin bind proteins are responsible for glycosyltransferase and transpeptidase reactions that lead to cross-linking of D-alanine and D-aspartic acid in bacterial cell walls. Without the action of penicillin binding proteins, bacteria upregulate autolytic enzymes and are unable to build and repair the cell wall, leading to bacteriocidal action. [1]
Medical side effects []
82 side effects listed on drug labels in SIDER 4.1 (amoxicillin).
- Diarrhoea
- Soft stools
- Headache
- Dysgeusia
- Vulvovaginal mycotic infection
- Vaginal moniliasis
- Nausea
- Vomiting
- Abdominal pain
- Gastrointestinal pain
- Pruritus
- Agranulocytosis
- Anaphylactic shock
- Anaemia
- Haemolytic anaemia
- Anxiety
- Mucocutaneous candidiasis
- Cholestasis
- Infection
- Confusional state
- Feeling abnormal
- Dermatitis exfoliative
- Dizziness
- Eosinophilia
- Toxic epidermal necrolysis
- Erythema multiforme
- Stevens-Johnson syndrome
- Dermatitis
- Rash
- Hypersensitivity
- Jaundice cholestatic
- Leukopenia
- Convulsion
- Convulsive seizure
- Serum sickness
- Thrombocytopenia
- Tooth discolouration
- Urticaria
- Agitation
- Hyperkinesia
- Hepatic function abnormal
- Leukocytoclastic vasculitis
- Crystalluria
- Tongue discolouration
- Infestation
- Thrombocytopenic purpura
- Acute generalised exanthematous pustulosis
- Insomnia
- Pseudomembranous colitis
- Hepatitis
- Angioedema
- Colitis
- Immune system disorder
- Tubulointerstitial nephritis
- Neutropenia
- Clostridium difficile colitis
- Enterocolitis haemorrhagic
- Renal failure
- Renal impairment
- Candida infection
- Vulvovaginal candidiasis
- Coma
- Epilepsy
- Flatulence
- Gastrointestinal disorder
- Glossitis
- Haemorrhage
- Haemoglobin
- Meningitis
- Nephritis
- Nervous system disorder
- Stomatitis
- Superinfection
- Urethral disorder
- Urinary tract disorder
- Dry mouth
- Skin disorder
- Rash erythematous
- Hepatobiliary disease
- Rash maculo-papular
- Body temperature increased
- Decreased appetite
Indications
- Asthma
- Bacteraemia
- Duodenal ulcer
- Endocarditis
- Endocarditis bacterial
- Escherichia coli infection
- Function kidney decreased
- Gonorrhoea
- Hypersensitivity
- Hypertrophic cardiomyopathy
- Infection
- Infectious mononucleosis
- Inflammation
- Mitral valve prolapse
- Pharyngitis
- Regurgitation
- Renal impairment
- Seasonal allergy
- Tonsillitis
- Urticaria
Subjective effects []
Legal status []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 33613, Amoxicillin. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/33613
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Amoxicillin. UNII: 9EM05410Q9. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9EM05410Q9
Amoxil Vials for Injection 500mg - Summary of Product Characteristics (SmPC). (emc). 4 November 2021. https://www.medicines.org.uk/emc/product/94/smpc
Amoxil (amoxicillin) Capsules, Tablets, Chewable Tablets, and Powder for Oral Suspension. DailyMed. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=49302
Amoxil: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050459
Trimox: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=061885
Moxatag (amoxicillin extended-release) Tablets Initial U.S. Approval: 1974. DailyMed. https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=364489
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 12:28:52 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 12:28:47 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 12:28:47 |
| gsrs | ok | 2026-11-20 12:28:48 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015193) | 2026-11-20 12:28:47 |
| kegg | ok | 2026-11-20 12:28:50 |
| pubchem | ok | 2026-11-20 12:28:47 |
| missing (no r/tripreports posts mention it) | 2026-11-20 12:28:47 | |
| sider | ok | 2026-11-20 12:28:48 |
| structure | ok | 2026-11-20 12:28:47 |
| wikipedia | ok | 2026-11-20 12:28:48 |